Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: The body was found on 26Mar2021 at around 8 a.m.; This is a spontaneous report from a non-contactable other healthcare professional (HCP) downloaded from the Agency Regulatory Authority-WEB, regulatory authority number DE-PEI-202100032180. A 57-years-old male patient received second dose of bnt162b2 (COMIRNATY, solution for injection, Lot Number: ER7812, expiry date not reported), via an unspecified route of administration on 25Mar2021 18:25 at 0.3 mL, single for covid-19 immunisation. Medical history included Hashimoto''s encephalopathy, acute respiratory failure, and bronchial pneumonia, all on unknown dates (not ongoing); and COPD, bipolar affective disorder, sleep apnoea syndrome, adipositas, autoimmune thyroiditis, arterial hypertension, all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient had the first dose of Comirnaty for COVID-19 immunisation at 0.3ml on 09Feb2021. The patient''s body was found on 26Mar2021 at around 8 a.m. The patient died on 26Mar2021 with unknown cause of death. It was unknown if an autopsy was performed. Sender comments: 2nd vaccination Comirnaty on 25Mar21 at 6:25 pm. After that, well-being. The corpse was found on March 26Mar21 at around 8 h. Comirnaty/ death/ Regulatory Authority, D. Unclassifiable No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Unknown cause of death
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166